Ondansetron Injection, Solution
Product Images NDC 0409-4759

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 0409-4759). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ondansetron 01)

FDA Label Image

Logo (Ondansetron 02)

FDA Label Image

Principal Display Panel (2 mL Vial Label)

Principal Display Panel (2 mL Vial Label)
This is a description for a 2mL single-dose vial containing Ondansetron injection, USP. Each vial has an NDC number of 04094755 and a concentration of 4mg/2mL (2mg/mL). The vial should be protected from light and is distributed by Hospira, Inc, located in Lake Forest, IL, USA.*
FDA Label Image

Principal Display Panel (2 mL Vial Carton)

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Principal Display Panel (20 mL Vial Label)
This is a 20 mL Multi-dose Vial of Ondansetron injection, USP, which contains 2 mg/mL. It is for IV or IM injection and is sterile. Each 1 mL of aqueous solution contains ondansetron 2mg. The vial contains buffers, preservatives and sodium chloride. The package insert contains dosage and administration details. It needs to be stored at 20 to 25°C and protected from light. The manufacturer is Hospira, Inc, Lake Forest IL 60045 USA.*
FDA Label Image

Principal Display Panel (20 mL Vial Carton)

Principal Display Panel (20 mL Vial Carton)
This is a description of a medication labeled as Ondansetron Injection USP with a 2mg dosage in a 20mL multi-dose vial. The medication contains sodium chloride and methylparaben and is intended for intravenous or intramuscular injection. It should be stored at a temperature of 2 to 8 degrees Celsius and protected from light.*
FDA Label Image

Principal Display Panel (20 mL Vial Tray)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.